CST2 expression reportedly promoted tumor progression by activating the PI3K/AKT pathway in pancreatic cancer54 and was also associated with disease progression in colon cancer,55 prostate cancer,56 and gastric cancer.57 This evidence concerns the gene CST2 and prostate carcinoma.